These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7022294)

  • 1. [Cardiologic monitoring of patients under adriamycin therapy].
    Höfling B; Bolte HD
    Onkologie; 1981 Jun; 4(3):174-8. PubMed ID: 7022294
    [No Abstract]   [Full Text] [Related]  

  • 2. Adriamycin cardiotoxicity.
    Bristow MR; Billingham ME; Mason JW
    Am J Cardiol; 1984 Jan; 53(1):263-4. PubMed ID: 6691272
    [No Abstract]   [Full Text] [Related]  

  • 3. Doxorubicin (adriamycin) cardiomyopathy.
    Saltiel E; McGuire W
    West J Med; 1983 Sep; 139(3):332-41. PubMed ID: 6356608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adriamycin-induced myocardial toxicity: new solutions for an old problem?
    Outomuro D; Grana DR; Azzato F; Milei J
    Int J Cardiol; 2007 Apr; 117(1):6-15. PubMed ID: 16863672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis of adriamycin myocardiopathy using echocardiography].
    Harpf H; Lehnert M; Tschech G
    Acta Med Austriaca Suppl; 1979; 6():341-3. PubMed ID: 299226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin-induced cardiomyopathy.
    Dunn J
    J Pediatr Oncol Nurs; 1994 Oct; 11(4):152-60. PubMed ID: 7946145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthracycline cardiotoxicity: recognition, management, and avoidance.
    Mason JW
    Compr Ther; 1979 Jul; 5(7):64-8. PubMed ID: 477286
    [No Abstract]   [Full Text] [Related]  

  • 8. [Characterization and comparison of the clinical and morphological changes in adriamycin cardiomyopathy].
    Bühner R; Henrichs J; Gottschalk R
    Onkologie; 1979 Feb; 2(1):24-7. PubMed ID: 392366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiomyopathy due to adriamycin: the possibility of its prevention. Monitoring by noninvasive technics].
    Bianchi L; Bertocchi C; Felci U; Ferrario G; Giani P; Mariani L; Medolago G; Sarti E
    Minerva Med; 1989 Mar; 80(3):215-26. PubMed ID: 2717043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Daunomycin-and adriamycin-induced cardiomyopathy--relationship between dosage of drugs and histopathological findings (author's transl)].
    Yamaguchi H; Toyota S; Takahara O; Ichimaru M
    Rinsho Ketsueki; 1978 Aug; 19(8):1041-50. PubMed ID: 713049
    [No Abstract]   [Full Text] [Related]  

  • 11. [New methods in early diagnosis of a cardiomyopathy caused by adriamycin].
    Bühner R; Gottschalk R
    Onkologie; 1978 Dec; 1(6):258-62. PubMed ID: 153507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adriamycin cardiomyopathy. Fatal outcome of general anaesthesia in a child with adriamycin cardiomyopathy.
    McQuillan PJ; Morgan BA; Ramwell J
    Anaesthesia; 1988 Apr; 43(4):301-4. PubMed ID: 3377152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fatal myocardiopathy due to adriamycin in spite of a reportedly non-dangerous cumulative dose].
    Battin J; Richir C; Bui NB; Hehunstre JP; Abecassis S
    Ann Pediatr (Paris); 1989 Feb; 36(2):136-40. PubMed ID: 2930128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Echocardiography with angiotensin administration in the diagnosis of adriamycin-induced cardiomyopathy].
    Göldel N; Autenrieth G; Werdan K; Knesewitsch P; Wilmanns W
    Z Kardiol; 1989 May; 78(5):320-7. PubMed ID: 2735093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of adriamycin cardiomyopathies].
    Cohen AM; Djaldetti M
    Harefuah; 1983 May; 104(9):401-5. PubMed ID: 6674054
    [No Abstract]   [Full Text] [Related]  

  • 16. Prenylamine inhibition of adriamycin-induced cardiomyopathy in mice.
    Milei J; Bolomo NJ; Marantz A
    Medicina (B Aires); 1982; 42(4):409-14. PubMed ID: 15171023
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental hepatopathy and myocardiopathy induced with adriamycin (histopathologic changes of the liver and myocardium caused by adriamycin in the rat)].
    Cuccurullo L; Vecchione R; Borrelli L; Battista O
    Pathologica; 1979; 71(1015):601-17. PubMed ID: 551385
    [No Abstract]   [Full Text] [Related]  

  • 18. Doxorubicin cardiomyopathy.
    Tri TB; Wilkins J
    Ann Intern Med; 1978 Jul; 89(1):137. PubMed ID: 666160
    [No Abstract]   [Full Text] [Related]  

  • 19. Adriamycin-induced cardiomyopathy.
    Compr Ther; 1979 Apr; 5(4):7. PubMed ID: 445992
    [No Abstract]   [Full Text] [Related]  

  • 20. Doxorubicin cardiomyopathy: underlying cause of interferon-induced cardiac dysfunction?
    Geffen DB; Liel-Cohen N
    Isr Med Assoc J; 2007 Sep; 9(9):690; author reply 690-1. PubMed ID: 17939640
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.